Lusine Abgaryan

Lusine (Lucy) Abgaryan, PhD, MBA, is an accomplished professional with extensive experience in biopharmaceuticals and business development. Currently serving as Co-Founder at GrittGene Therapeutics, Lusine is focused on developing innovative treatments for Myotonic Dystrophy Type 2. As a Business Development Advisor at Foldink 3D Bioprinting and Founder of Proone Labs, Lusine leverages expertise to drive business growth. Lusine co-founded Decano Analytical Laboratories, LLC, overseeing operations and regulatory affairs, while prior roles at Scripps Research involved advancing in-vitro pharmacology efforts for GPCR targets. With a strong educational background, including a PhD in Biophysics from Yerevan State University and an MBA from the University of California, San Diego, Lusine combines scientific acumen with strategic business insights.